Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432393
Status:
COMPLETED
Last Update Posted:
2008-10-20
First Post:
2007-02-06
Brief Title:
Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Shahid Beheshti University of Medical Sciences
Study Overview
Official Title:
Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose There are some controversies about the effect of Levodopa-Carbidopa on treatment of non-arteritic anterior ischemic optic neuropathy NAION This study was performed to evaluate the effect of Levodopa-Carbidopa on visual acuity color vision and visual field in patients with recent onset NAION less than 6 weeks duration
Patients and Methods In this double-blind randomized clinical trial 13 patients were treated with levodopa-carbidopa and 12 patients took placebo for 3 weeks Visual acuity color vision and visual field were tested before and at 4th 12th 16th and 24th weeks after enrollment and evaluated
Patients and Methods In this double-blind randomized clinical trial 13 patients were treated with levodopa-carbidopa and 12 patients took placebo for 3 weeks Visual acuity color vision and visual field were tested before and at 4th 12th 16th and 24th weeks after enrollment and evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None